Logo
C

CytoReason

133 employees

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Combinations
Artificial Intelligence
Target Discovery
Cells
Biopharma
Indication Prioritisation
Indications
Inflammatory Bowel Disease
Health Diagnostics
Health Care
Data Science
Atopic Dermatitis
Bioinformatics
Cancer Immunotherapy
Patient Stratification
Biomarker Discovery
Machine Learning
Immune System
Computational Drug Discovery

Date founded

2016

Funding rounds raised

C

CytoReason raised undisclosed on January 4, 2022

Investors: Asymmetry Ventures

C

CytoReason raised undisclosed on June 9, 2021

Investors: OurCrowd

FAQ